购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Apoptosis
    (2)
  • Syk
    (1)
  • Tyrosine Kinases
    (1)
  • Others
    (5)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (3)
  • 5日内发货
    (1)
  • 6-8周
    (2)
  • 8-10周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "itk inhibitor 2"的结果
筛选
搜索结果
TargetMol产品目录中 "

itk inhibitor 2

"的结果
  • 抑制剂&激动剂
    8
    TargetMol | Inhibitors_Agonists
  • ITK inhibitor 2
    T116901309784-09-5
    ITK inhibitor 2 (compound 4)是一种高效和选择性 ITK 抑制剂,IC50= 2 nM。
    • ¥ 497
    In stock
    规格
    数量
  • PF-06465469
    T164931407966-77-1
    PF-06465469 is a covalent ITK inhibitor(IC50: 2 nM).
    • ¥ 2480
    5日内发货
    规格
    数量
  • PRN694
    T165781575818-46-0
    PRN694 shows extended target residence time on ITK and RLK, enabling durable attenuation of effector cells in vitro and in vivo. PRN694 is an irreversible, highly selective, and effective covalent interleukin-2-inducible T-cell kinase (ITK) and resting ly
    • ¥ 19950
    3-6月
    规格
    数量
  • CTA 056
    T355691265822-30-7
    CTA 056 是白细胞介素-2 诱导的 T 细胞激酶(ITK)抑制剂,抑制小鼠 MOLT-4 异种移植肿瘤的生长,诱导 Jurkat 细胞凋亡,可用于研究自身免疫性疾病和T细胞恶性肿瘤。
    • ¥ 1980
    In stock
    规格
    数量
  • ITK inhibitor
    T37604439574-61-5
    Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcepsilonR-mediated signaling pathways. ITK inhibitors can be used for the treatment of inflammation and immune-mediated disorders. ITK inhibitor (N-[5-[[3-[(4-Acetylpiperazin-1-yl)carbonyl]-4-methyl-6-methoxy-phenyl]thio]thiazol-2-yl]-4-(N-1,2-dimethylpropylaminomethyl)benzamide) is the analogue of BMS-509744, which can potently and selectively inhibit Itk kinase activity. In vitro: BMS-509744 could reduce TCR-induced functions including PLCγ1 tyrosine phosphorylation, calcium mobilization, IL-2 secretion, and T-cell proliferation in vitro in both human and mouse cells [1]. In vivo: BMS-509744 suppressed the production of IL-2 induced by anti-TCR antibody administered to mice. BMS-509744 also significantly diminishes lung inflammation in a mouse model of ovalbumin-induced allergy/asthma [1]. Clinical trial: Up to now, both BMS-509744 and ITK inhibitor is still in the preclinical development stage.
    • ¥ 12800
    8-10周
    规格
    数量
  • ITK/TRKA-IN-1
    T402942655557-54-1
    ITK TRKA-IN-1 is a chemical compound that functions as a dual inhibitor of IL-2-inducible T-cell kinase (ITK) and tropomyosin receptor kinase A (TRKA). With an IC50 value of 1.0 nM, it effectively inhibits the activity of ITK, while demonstrating a remarkable 96% inhibition of TRKA.
    • ¥ 52400
    6-8周
    规格
    数量
  • BAY 61-3606
    2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺, Syk inhibitor IV
    T4263732983-37-8
    BAY 61-3606 (Syk inhibitor IV) 是一种具有口服活性的,ATP 竞争性的可逆选择性Syk 抑制剂。它作用于乳腺癌细胞,通过下调 Mcl-1 促进 TRAIL 诱导的细胞凋亡。它降低神经母细胞瘤细胞中的 ERK1 2 和 Akt 磷酸化,也降低 K-rn 细胞裂解物中 Syk 磷酸化。
    • ¥ 453
    In stock
    规格
    数量
  • ITK inhibitor 6
    T632292404604-06-2
    ITK inhibitor 6 是选择性的、有效的 ITK 抑制剂,能够作用于 ITK (IC50: 4 nM)、BTK (IC50: 133 nM)、JAK3 (IC50: 320 nM)、EGFR (IC50: 2360 nM)、LCK (IC50: 155 nM)。ITK inhibitor 6 对 PLCγ1 和 ERK1 2 的磷酸化具有抑制作用,表现出抗增殖效果。
    • ¥ 46800
    10-14周
    规格
    数量
没有更多数据了